Pacira BioSciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Brisbane, CA
PCRX chart
What traders are saying about $PCRX
Latest postsPacira BioSciences, Inc. news
- IBRX Stock Rises Overnight: Jim Cramer Backs ImmunityBio As A ‘Very Good Spec’ Amid Biotech Takeover Wave
stocktwits.com ·
- ETFs Are Net Sellers of Pacira BioSciences (PCRX) on Oct. 22
GuruFocus ·
- Is Pacira BioSciences (PCRX) Fully Valued On The Viatris Takeover Offer?
Simply Wall Street ·
- Pacira BioSciences, Inc. (PCRX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Viatris Inc. (VTRS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Pacira BioSciences, Inc. Estimates – NASDAQ:PCRX
TradingView ·
- How Pacira Biosciences Inc. (PCRX) Affects Rotational Strategy Timing
Stock Traders Daily ·
- Pacira BioSciences (PCRX) Stock Gets Fair Value Boost After Viatris Deal Framing
Yahoo Finance ·
- PCRX Q3'26 Earnings: revenue estimate is 182.87M USD
TradingView ·
- Pacira BioSciences, Inc. (PCRX) Stock Forecasts
Yahoo! Finance Canada ·
- Stocktwits M&A Watch: Viatris-Pacira Deal, Coca-Cola’s Costa Coffee Sale, Devon’s Eagle Ford Divestiture In Focus
stocktwits.com ·
- Stocktwits Biotech Dealmaker — Viatris And GE Healthcare Buy What They Can Sell; Biohaven And Alector Sell Rights
stocktwits.com ·
Pacira BioSciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $726.4M | $701.0M | $675.0M | $666.8M |
| Net income | $7.0M | -$99.6M | $42.0M | $15.9M |
| Diluted EPS | $0.16 | $-2.15 | $0.89 | $0.34 |
| Total assets (year end) | $1.26B | $1.55B | $1.57B | $1.68B |
| Cash and equivalents (year end) | $158.5M | $276.8M | $153.3M | $104.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KFORM 8-K
- 10-Q10-Q - PCRX - 06.30.2026
- 8-K8-K
- 8-K8-K
- 8-K8-K
- 10-Q10-K - PCRX - 03.31.2026
- 8-K8-K
- 10-K10-K - PCRX - 12.31.2025
- 8-K8-K
- 8-K8-K
- 8-K8-K
- 10-Q10-Q
About Pacira BioSciences, Inc.
- Ticker
- PCRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Brisbane, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1396814
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
Frequently asked questions
What exchange is Pacira BioSciences, Inc. listed on?
Pacira BioSciences, Inc. trades on the Nasdaq under the ticker symbol PCRX.
What industry is Pacira BioSciences, Inc. in?
Pacira BioSciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Pacira BioSciences, Inc. headquartered?
Pacira BioSciences, Inc.'s business address on file with the SEC is in Brisbane, CA.
When does Pacira BioSciences, Inc.'s fiscal year end?
Pacira BioSciences, Inc.'s fiscal year ends on December 31.
How much revenue did Pacira BioSciences, Inc. report?
Pacira BioSciences, Inc. reported $726.4M in revenue for calendar year 2025, according to its SEC filings.